231 related articles for article (PubMed ID: 18229415)
21. Uncovering the benefits of aspirin.
Johns Hopkins Med Lett Health After 50; 2007 Feb; 18(12):3. PubMed ID: 17340747
[No Abstract] [Full Text] [Related]
22. No one-size-fits-all for aspirin and elders.
Harv Heart Lett; 2005 Sep; 16(1):7. PubMed ID: 16211726
[No Abstract] [Full Text] [Related]
23. Aspirin as antiplatelet agent in diabetes: Cons.
Mannucci PM
Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
[No Abstract] [Full Text] [Related]
24. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
Fisher M; Knappertz V
Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
[No Abstract] [Full Text] [Related]
25. Summaries for patients. The effect of low-dose aspirin on colorectal cancer risk in women.
Ann Intern Med; 2013 Jul; 159(2):I-24. PubMed ID: 23856695
[No Abstract] [Full Text] [Related]
26. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
[TBL] [Abstract][Full Text] [Related]
27. Re: Sørensen et al.: low dose aspirin.
Petroski D
Am J Gastroenterol; 2001 May; 96(5):1646. PubMed ID: 11374720
[No Abstract] [Full Text] [Related]
28. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
[TBL] [Abstract][Full Text] [Related]
29. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
Jolly SS; Pogue J; Haladyn K; Peters RJ; Fox KA; Avezum A; Gersh BJ; Rupprecht HJ; Yusuf S; Mehta SR
Eur Heart J; 2009 Apr; 30(8):900-7. PubMed ID: 18819961
[TBL] [Abstract][Full Text] [Related]
30. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous macular haemorrhage in a patient on aspirin.
Elgohary MA; Gormley PD
J Postgrad Med; 2005; 51(2):153-5. PubMed ID: 16006717
[No Abstract] [Full Text] [Related]
32. [Safety of specific cyclo-oxygenase 2 inhibitors].
Knol A
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478-9. PubMed ID: 11503324
[No Abstract] [Full Text] [Related]
33. Aspirin: a user's guide to who needs it and how much to take. Just because you can buy aspirin without a prescription (and for pennies a tablet) doesn't mean everyone should be taking it to prevent a heart attack or stroke.
Harv Heart Lett; 2007 Aug; 17(12):3-6. PubMed ID: 17717889
[No Abstract] [Full Text] [Related]
34. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
35. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
Jähne J; Schirren J
Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
[No Abstract] [Full Text] [Related]
36. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
37. How much aspirin?
O'Brien JR; Etherington MD
Thromb Haemost; 1990 Nov; 64(3):486. PubMed ID: 2096494
[No Abstract] [Full Text] [Related]
38. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
39. Ethical considerations in relation to aspirin prophylaxis.
Morgan G
Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
[TBL] [Abstract][Full Text] [Related]
40. [Hemorrhagic stroke antithrombotic drugs].
Alvarez-Sabín J
Rev Neurol; 2001 May 1-15; 32(9):848-50. PubMed ID: 12803195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
